Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let me reassure the longs on this board that I spoke recently to Titan about any issues pending for fda submission and was reassured without getting any insider information ie everything is publically known, that they are on time with animal data and that the only concern which they are taking care of is new fda guidelines on sterility which came from issues with endoscopy equipment sterilization techniques.
The design of the system will be set 1st to 2nd quarter of 2018, as you all know the manufacturing and software is outsourced and the vendors have been ahead of schedule now that there is monies to pay them.
Stay positive I have good insight into this market and believe in the next two years the holders of this stock at these prices will be rewarded nicely.
Bought again at .36
I have great confidence in the management after being in this for four years definitely dont let daily changes in price freak you out. We are almost guaranteed to summit to fda this year wow what a gift given where the company was this time last year. Retire 2019 $$
The issue of a reverse split of a stock to upgrade to the nasdaq and whether this is a negative or positive issue depends completely why the company is upgrading. If it upgrades with no support from wall street investors, ie stock purchase into funds, promotion of the company to investors who are not familiar with the robotic surgery market, which is most of the population well prior to the upgrade the stock would drop.
If you listened to Mcnally on the last CC he is clearly aware of the how important managing the upgrade to the nasdaq will be and what ever the RS is if necessary will not effect your Market value of your portfolio. To really get this stock moving we need to be off the pink sheets and a perfect time is right after filing with the FDA. I am pretty confident that is the same feelings of the management. At that point you get excellent press from the financial media and an easier sell the the fund managers who need to manage risk.
I agree with the people on the board that 2018 will be a defining year for this company, and at least we have the money to get there!!!
had open order for 50000 shares at .371 and filled like 18000 shares, even when volume was light in the middle of the day price would not move .001 cents lower to fill order. Shows that market makers with shares are not willing to discount much because of the fact that the company is well funded now and feel that the upside has moved significantly positive.
A company could buy up shares on the open market but for us that would force the price up anyway, like anytime a party takes an interest in a specific company. There is no need to raise more money at this time since they will be funded past submission with cash on hand and warrants that will be converted to stock. A great place to be if you have been buying from 10 cents to now.
Possible upgrade to smaller camera so could fit another instrument via port site for assistant to use without having to move away from single port surgery platform and marketing.
At this point the number of outstanding shares and dilution is not the critical issue. If you don't have money to pay your vendors to produce the hardware and software to get to fda submission the game is over and your investment is lost. The management has done a golden job in turning around the company to get investors to believe in the product and the management team to meet goals and perform. As more physicians have seen the product and meet with the management team confidence has grown to this point where 2018 can produce sizable gains for investors especially when you can still buy the stock at 38 cents.
This company is minimally known outside of the robotic community but when wall street takes an interest the upside will be swift. Just like all R&D companies once the product is proven that is when the real value is generated.
NP we all win with good up to date information, there is only 310 followers on this message board but some very strong connections to the company.
Just spoke with a physician friend at Columbia who filled me in about the time lines for the robot there and the one being installed in Europe. The columbia robot is being updated with some new tech based on physician feedback and then will complete animal work first quarter 2018 for submission to the fda later in 2018. Press releases on that most likely end of December. Most of the effort from the vendors is in Europe getting that system up and than have more press with european surgeons and that system will also finish up the animal testing. Absolutely stated that the fda submission will be on time or early as long as not any changes by fda on sterilizaion data to be submitted.
The recent raise of cash was a huge plus to other investors in wall street and he said that the ability to uplist to the nasdaq without much more dilution or even a reverse split is a real possibility now held by the management and advisors from wall street to the company.
He was sad that he could not buy into the recent offer and will be adding to his position this week given the strong cash position of the company.
Wow what a change from this time last year.
Jolyon Burton emailed me back and stated that the new extension of the offering is already sold out. Thats crazy can't give my money away!
Will try to buy another 100000 shares via the offer expansion which is at 39 cents US plus one warrant definitely a great deal. Left email with Burton as well as phone call. Hopefully can get in on deal. States that will sell in US with brokers within the US. And with top amount upto 23000000 CND hopefully will have room for some of us on this board.
Next week will be a slow week with Thanksgiving, the main run up will be first quarter of 2018 as they prepare for uplisting. Just keep eye out for some opportunities when people want to sell to counter gains. Cant rebuy for 30 days otherwise lose offset to gains.
Stay alert for those drops but dont worry will come back up quickly.
Happy thanksgiving
Agree 100 percent
Depends on the size of the specimen, if small enought put in a bag and removed from port site. If large you have to either extend the incision or bring the specimen if left colon out via the rectum. Like I have said before this platform will be a tool in the arsenal of a surgeon. You may need extra 5mm or 3mm ports to complete your procedure with an assistant. For me I would like to use this platform for complex ventral hernias, bilateral inguinal hernias, low pelvic colon surgery and for esophageal resection and esophageal reflux surgery.
Maybe if the stock performs well I can retire!!
The big news will be when they move up the date for fda submission which is the main reason for the raises so quickly as stock price rises. Ultimately the best thing for the company is to shorten the time to get fda approval and sell units. Management's main goal is to get out of r&d phase as quickly as possible. This will benefit shares holders far greater than worrying about the words in a PR release. Share dilution will always occur but as the ceo said try to minimize by reaching time lines sooner than expected. I believe he is moving the company in a positive way and this is what supports share price.
The next raise may be at a higher number than .39 cents you never know so buying today could look smart. But thats the fun when you gamble, the thrill of victory and the agony of defeat. Good luck all.
I guess I should contact investor relations personally and maybe get those on this board who want to get some special treatment together for an investment. What do you think? I already own 360000 shares lets make it an even 500000 with some warrants.
The lady on the phone said you would have to email the dealer ahead of time to be in the offering. How would we have known that? I do believe that management should contact present stock holders as a sign of respect to those who have supported the company about offering in the future.
There seems to be some on the board who do not understand how a company works especially a start up r&d healthcare company. It is amazing that this company did not go out of business earlier this year. To think that they got three devices produced and placed at impressive sites is a major milestone for the new execs. Even more impressive is the amount of funding in a short period of time the company has acquired to support continued operations. You have to have money in the bank to get vendors to work with you in a timely fashion. Hopefully we will get fda submission before any RS which will reward all of us on the board. Since 2014 when I first invested, I feel the most positive with the management.
The phone number for the offering company is 14166407575 and if you call and ask about buying shares see what they say. I am not posting lies on this board. Check it out yourself.
Overall getting the fda submission funded is a major milestone and should bring the pps back to high 40's quickly. Just think about the pps bounce on that day. Wow
Warrants at higher price point and demand was from investorslike us who would like to be in on favorable deals. The benefit of not buying the offering is you dont lock up tour investment for a time period. Thats my best guess. Would like to get some inside deals too.
Just spoke to Blum Burton on the phone who is managing the offering. The entire offering was bought by 9:15am before the market opened.She said that they had so many calls to buy that they may open another offering November 30th to the public. Definitely a good day to buy at these prices. Need to be an insider to get these deals I guess but shows high demand for stock from new investors.
50 cnd equals .39 cents us
Plus get full warrant at call price of 60cdn
Would only buy stock today at low 30's or buy offering via broker
Remember how the stock jumped when 12 surgeons invested 2 million. The board was excited. Dont sell into the news you will be sorry in a week.
Investing in high risk companies requires a high tolerance for market swings but also an informed basis for the product you invest in. As a surgeon who constantly is approached about buying new tech for my hospital system, I invested in this company because I believe it fills a void for a lower cost robotic system that is mobile from OR to OR. My main concern over the past year was whether the tech would execute as described by Titan. So far the PR has been positive and my inside contacts in new york confirm this. So I believe it is not BS. All on this board should look where we were one year ago. I had almost been resolved to a total loss of my investment and now in the green.
The company needs more liquidity to continue to have share price rise. It would actually be a negative sign if new funds where not coming in at this point. Any drop below 40 is a awesome entry point again.
Buying stock does not generate working capital only stock dilution or borrowing from the bank money. If people are willing to buy stock better for all of us since no interest to be paid back. Shows confidence in company. Stay positive. Dont sell into news will regret it in the long run.
To all of the negative posts I will say that having 7 months of money to run a company is cutting it close. Think about it you have to make sure your vendors are paid as well as staff. It takes time to acquire funds and how would it sound to the market if they ran out of funds. It is important to keep the new funds coming in and this actually instills confidence in future investors. I would be happy to buy shares with a half warrant at .40 cents.
The company definitely needs more money to be able to reverse split and show the institutional investors that there is money behind the tech. Just spoke with my patient whose business is taking pink sheet companies to the nasdaq and said that titan definitely needed more liquid funds before it could be uplisted. Investors dont want more dilution after they sell to there investors. They always have concerns about their reputation when selling new listings.
You always have to expect more dilution in a company that was mismanaged for years but believe in the end will have a decent buy out price.
Would love price drop to the 20 cent range buy lots more after weak hands are squeezed out.
I have invested in this type of r&d company before and the profitable ones timed there upgrade to the nasdaq well. The only way to get continual monies entering the company is to have institutions having the ability to invest.
When this happens you will see the best returns on your investment.
Many of you like myself bought at the lows to average out your average price per share and are in the green but selling now I would pay short term gains rate of 39% and state rate of 8% and hate to give half of profits to uncle sam.
Hoping to get past one year before buy out.
If you are a warrant holder you own the stock, and since the only way to make money on the warrant is to convert to shares why would you not want to support the company. It is in your best interest once your warrant price is in the money.
the question about uplisting to the nasdaq confirmed my belief that there will be a 5 to 1 reverse split once the stock gets closer to one dollar and they get close to filing for fda approval. This will allow institutions to invest and support price growth.
The single port system attaches to the xi system.
Many cases require an assistant to hold tissue away from the area of the operation or to help with counter traction for easier dissection. Also having a suction port can be essential for certain procedures.
Yes you only have two hands but if you can use the third instrument for retraction of tissue that is an advantage.
The davinci system will compete with Sport. The advantages of the Sport system have to be the following:
Lower Price to acquire
Smaller foot print and easily moved from room to room
Lower cost of maintenance
Better ergonomic work station
Need to have great sales/education staff
I see the Sport as a robotic instrument that will need other small ports to complete certain procedures.
The problem with any single port system is the size of the port. The main morbidity from the trocar is hernia creation at the site and pain at the site. I personally would rather have 4 5mm holes in my abdominal wall than one large painful hole. That has been the draw back to single site surgery over the past 5 years.
Will have to compare the port sizes between the two systems.
However certain operations require removal of a specimen, i.e. large gallstones, colon, uterus, spleen therefore the port site can be used and there is no downside.
What do all of the longs think about management buying shares at 20cents when the price is 35cents.
They can't sell those shares for a year but giving themselves discounted shares feels slimey.
Just to give some surgeon feed back about the system I will rewind my investment history with Titan. Went to a sages conference about 3 years ago when Titan had a prototype for display and try me. The platform was great for my laparoscopic ventral hernia repairs especially for obese people since straight instruments even with Davinci has some limits for retro-rectus repair of the defect.
Invested at that time not huge dollars and hoped for some progress with a start up. Obviously did not happen but started buying some as dropped and bought a lot of shares below 25 cents.
As a surgeon love the platform, as an investor hope for an early buy out by a large firm so the device can make it to market without more dilution and typical insider stock deals that really do undermine the common investors confidence in management.
I hope to take a look at the device in NYC soon. The great thing is we are not vested in a drug just a machine, a lot fewer hurdles to the finish line.
that is the great thing about message boards and investors in high risk stocks who really need the money that they invest, they get scared quickly when the see their paper returns disappear. This stock is not well known and has a lot of outstanding shares which makes it very volatile from day to day.
The good thing is that when somebody sells somebody is buying and the smart money will pick up the shares at this time when all of the good news starts to roll out. This company finally has units out in hospitals for physicians to see and work with. That is a huge positive and why the stock has risen so quickly.
Hopefully my crystal ball's batteries don't run out...
great day to buy before news from NYC gets released!
Can't change the past only the future. PPS will be dependent on meeting goals and does the sport unit perform well at the sites.
Investors like myself who bought shares at 2 dollars already took that hit. By buying low priced shares at ten cents when management changed, it is starting over with a new company. That investment has gone up 400 percent and has offset the previous loss.
From this point forward,just like in the past your money can multiply or divide rather quickly.
Hold on to your pants.
If a company has to reverse split to get up listed to a better exchange it must have all of its ducks in a row. Must have institutions on board, must have meet major goals and must have done a great PR job with present investors explaining why now and that not a sign of desperation.
I far I can tell definitely not quite there yet. It is not the pps that is the major factor as to if it occurs.
This is from a patient whose company specializes in just this type of business taking companies from pink sheets to the nasdaq which usually requires a RS.